Kraj: Stany Zjednoczone
Język: angielski
Źródło: NLM (National Library of Medicine)
Liothyronine Sodium (UNII: GCA9VV7D2N) (LIOTHYRONINE - UNII:06LU7C9H1V)
AX Pharmaceutical Corp
Liothyronine Sodium
LIOTHYRONINE 4.95 g in 5 g
NOT APPLICABLE
Bulk Ingredient For Animal Drug Compounding
X- LIOTHYRONINE SODIUM POWDER AX PHARMACEUTICAL CORP ---------- X AX Pharmaceutical Corp liothyronine sodium powder PRODUCT INFORMATION PRODUCT T YPE BULK INGREDIENT ITE M CODE (SOURCE ) NDC:6 2157-40 8 ROUTE OF ADMINISTRATION NOT APPLICABLE ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH LIO THYRO NINE SO DIUM (UNII: GCA9 VV7D2N) (LIOTHYRONINE - UNII:0 6 LU7C9 H1V) LIOTHYRONINE 4.9 5 g in 5 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH WATER (UNII: 0 59 QF0 KO0 R) PRODUCT CHARACTERISTICS COLOR ye llo w S CORE S HAP E S IZ E FLAVOR IMPRINT CODE CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 2157-40 8 -0 1 5 g in 1 JAR 0 4/11/20 17 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITA TIO N MARKE TING START DATE MARKE TING END DATE bulk ingredient fo r animal drug c o mpo unding 0 4/11/20 17 LABELER - AX Pharmaceutical Corp (202924858) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS AX Pharmaceutical Co rp 20 29 248 58 pack(6 2157-40 8 ) , relabel(6 2157-40 8 ) Revised: 4/2017 Przeczytaj cały dokument